BioCentury

8:00 AM GMT, Feb 28, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Status

Aflibercept: Completed Phase II enrollment

Regeneron disclosed in its 4Q10 earnings that partner sanofi-aventis completed enrollment of about

Read the full 136 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.